Literature DB >> 15377899

Flash visual evoked potentials predict visual outcome in traumatic optic neuropathy.

Mark D Holmes1, Bryan S Sires.   

Abstract

PURPOSE: To determine the significance of flash visual evoked potentials (FVEP) in the evaluation of patients with traumatic optic neuropathy (TON).
METHODS: Eleven head-injured patients admitted to our center were diagnosed with unilateral TON. For every patient, FVEPs were obtained in both the affected eye and the unaffected eye. The normal eye thus functioned as each subject's internal control. We determined the amplitudes of FVEP waveforms for each eye and calculated an amplitude ratio of the affected/normal side for all individuals. The best-corrected visual acuity was obtained for each eye 2 weeks after acute hospitalization. We then determined the relation between best-corrected visual acuity in TON and the FVEP amplitude ratio.
RESULTS: In 4 patients in whom the amplitude ratio was at least 0.5, visual acuity in the affected eye was 20/30 or better. In 7 patients, the amplitude ratio was less than 0.5, and visual acuity in the eye with TON did not exceed 20/300 (Pearson r = -0.93, p = 0.0001).
CONCLUSIONS: Flash visual evoked potentials are highly predictive of the degree of visual function in unilateral TON. Finding FVEP amplitudes that are at least 50% of the normal eye appears to be critical in anticipating good, long-term visual outcome.

Entities:  

Mesh:

Year:  2004        PMID: 15377899     DOI: 10.1097/01.iop.0000134272.55294.4c

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  11 in total

1.  Clinical Evaluation and Treatment Outcome of Traumatic Optic Neuropathy in Nepal: A Retrospective Case Series.

Authors:  Sanjeeta Sitaula; Hira Nath Dahal; Ananda Kumar Sharma
Journal:  Neuroophthalmology       Date:  2017-06-21

Review 2.  Traumatic optic neuropathy: a review.

Authors:  Arjunan Muthu Kumaran; Gangadhara Sundar; Lim Thiam Chye
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2014-11-25

Review 3.  Traumatic optic neuropathy: a review of current studies.

Authors:  Bin Chen; Hengsen Zhang; Qing Zhai; Huaipeng Li; Chunxia Wang; Yong Wang
Journal:  Neurosurg Rev       Date:  2022-01-16       Impact factor: 3.042

4.  Prognosticators of Visual Acuity After Indirect Traumatic Optic Neuropathy.

Authors:  Alex J Wright; Joanna H Queen; Emilio P Supsupin; Alice Z Chuang; John J Chen; Rod Foroozan; Ore-Ofe O Adesina
Journal:  J Neuroophthalmol       Date:  2022-03-25       Impact factor: 4.415

5.  Intranasal injection of recombinant human erythropoietin improves cognitive and visual impairments in chronic cerebral ischemia rats.

Authors:  Yanhui Zhou; Bin Sun; Junhong Guo; Guohong Zhou
Journal:  Biomed Rep       Date:  2020-08-25

6.  Predictive value of visual evoked potentials, relative afferent pupillary defect, and orbital fractures in patients with traumatic optic neuropathy.

Authors:  Seyed Ali Tabatabaei; Mohammad Soleimani; Mahdi Alizadeh; Morteza Movasat; Mohammad Reza Mansoori; Zakieh Alami; Alireza Foroutan; Mahmood Joshaghani; Saeid Safari; Arzhang Goldiz
Journal:  Clin Ophthalmol       Date:  2011-07-25

7.  Concomitant optic nerve transection and chorioretinitis sclopetaria.

Authors:  Mehrdad Mohammadpour; Masoud Soheilian
Journal:  BMC Ophthalmol       Date:  2005-12-22       Impact factor: 2.209

8.  Traumatic optic neuropathy-Clinical features and management issues.

Authors:  Patrick Yu-Wai-Man
Journal:  Taiwan J Ophthalmol       Date:  2015-03-01

9.  The Role of the Flash Visual Evoked Potential in Evaluating Visual Function in Patients with Indirect Traumatic Optic Neuropathy.

Authors:  Mai A Mohammed; Ehab Mossallam; Ibrahim Y Allam
Journal:  Clin Ophthalmol       Date:  2021-03-30

10.  Visual-Evoked-Response-Supported Outcome of Intravitreal Erythropoietin in Management of Indirect Traumatic Optic Neuropathy.

Authors:  Mohammad Ahmad Rashad; Ahmed Abdel Meguid Abdel Latif; Hazem A Mostafa; Samah Mahmoud Fawzy; Mahmoud Abdel Meguid Abdel Latif
Journal:  J Ophthalmol       Date:  2018-12-16       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.